<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Fibroblast activating protein-α expression in squamous cell carcinoma of the esophagus in primary and irradiated tumors: the use of archival FFPE material for molecular techniques.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Fibroblast activating protein-α expression in squamous cell carcinoma of the esophagus in primary and irradiated tumors: the use of archival FFPE material for molecular techniques." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484010/bin/ejh-61-2-2793-g003.jpg"/> </div> <div class="text-side"> <h1>Fibroblast activating protein-α expression in squamous cell carcinoma of the esophagus in primary and irradiated tumors: the use of archival FFPE material for molecular techniques.</h1> <p>Quantification of IHC staining for FAP-α. Bar chart shows a statistically significant increase (average fold change of 2.7) in the intensity of staining in tumor tissues compared to normal tissues. The fold change indicates the ratio of mean gray values of normal to cancer tissues. Images are representative cases of IHC staining at a total magnification of 400x. They show the weakest (A) and the strongest (B) FAP-α immunoreactivity in esophageal normal and cancer tissues, respectively.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/28735527/" target="_blank">28735527</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>